Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00965666 · ClinicalTrials.gov registry record · Early Phase 1
Pilot Study of Etanercept (Enbrel) in Children With Fanconi Anemia
A Early Phase 1 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 3
- Enrollment target
NCT00965666 is a Early Phase 1 study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 3 participants.
The verdict
NCT00965666, a Early Phase 1 study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate the safety of the drug Etanercept (Enbrel) and to determine if this drug can help in the treatment of early bone marrow failure in patients with Fanconi anemia.
Interventions
- DRUG Etanercept
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2005-10 |
| Est. Completion | 2010-10 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00965666
The ClinicalTrials.gov registry entry for NCT00965666 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Etanercept is the first listed.
NCT00965666 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00965666 about?
NCT00965666 is a clinical study titled "Pilot Study of Etanercept (Enbrel) in Children With Fanconi Anemia". The purpose of this research study is to evaluate the safety of the drug Etanercept (Enbrel) and to determine if this drug can help in the treatment of early bone marrow failure in patients with Fanconi anemia.
What is the current status of trial NCT00965666?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 3 participants. The study started on 2005-10. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00965666?
The interventions under investigation include: Etanercept (DRUG).
Who is sponsoring clinical trial NCT00965666?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.